Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP544080.RAToeMfq90dsmHcIKpYcoCjFV37E84le3EmROoRtACxKU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP544080.RAToeMfq90dsmHcIKpYcoCjFV37E84le3EmROoRtACxKU130_assertion type Assertion NP544080.RAToeMfq90dsmHcIKpYcoCjFV37E84le3EmROoRtACxKU130_head.
- NP544080.RAToeMfq90dsmHcIKpYcoCjFV37E84le3EmROoRtACxKU130_assertion description "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP544080.RAToeMfq90dsmHcIKpYcoCjFV37E84le3EmROoRtACxKU130_provenance.
- NP544080.RAToeMfq90dsmHcIKpYcoCjFV37E84le3EmROoRtACxKU130_assertion evidence source_evidence_literature NP544080.RAToeMfq90dsmHcIKpYcoCjFV37E84le3EmROoRtACxKU130_provenance.
- NP544080.RAToeMfq90dsmHcIKpYcoCjFV37E84le3EmROoRtACxKU130_assertion SIO_000772 23393682 NP544080.RAToeMfq90dsmHcIKpYcoCjFV37E84le3EmROoRtACxKU130_provenance.
- NP544080.RAToeMfq90dsmHcIKpYcoCjFV37E84le3EmROoRtACxKU130_assertion wasDerivedFrom befree-20150227 NP544080.RAToeMfq90dsmHcIKpYcoCjFV37E84le3EmROoRtACxKU130_provenance.
- NP544080.RAToeMfq90dsmHcIKpYcoCjFV37E84le3EmROoRtACxKU130_assertion wasGeneratedBy ECO_0000203 NP544080.RAToeMfq90dsmHcIKpYcoCjFV37E84le3EmROoRtACxKU130_provenance.